- Home
- TAIT vs CLDI Comparison
TAIT vs CLDI Comparison
Compare TAIT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- CLDI
- Stock Information
- Founded
- TAIT 1989
- CLDI 2014
- Country
- TAIT United States
- CLDI United States
- Employees
- TAIT N/A
- CLDI N/A
- Industry
- TAIT Electronic Components
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TAIT Technology
- CLDI Health Care
- Exchange
- TAIT Nasdaq
- CLDI Nasdaq
- Market Cap
- TAIT 15.7M
- CLDI 15.7M
- IPO Year
- TAIT 1995
- CLDI N/A
- Fundamental
- Price
- TAIT $2.27
- CLDI $0.41
- Analyst Decision
- TAIT
- CLDI Strong Buy
- Analyst Count
- TAIT 0
- CLDI 2
- Target Price
- TAIT N/A
- CLDI $15.00
- AVG Volume (30 Days)
- TAIT 11.1K
- CLDI 202.0K
- Earning Date
- TAIT 05-23-2025
- CLDI 05-20-2025
- Dividend Yield
- TAIT 8.81%
- CLDI N/A
- EPS Growth
- TAIT N/A
- CLDI N/A
- EPS
- TAIT 0.15
- CLDI N/A
- Revenue
- TAIT $4,141,000.00
- CLDI N/A
- Revenue This Year
- TAIT N/A
- CLDI N/A
- Revenue Next Year
- TAIT N/A
- CLDI N/A
- P/E Ratio
- TAIT $15.15
- CLDI N/A
- Revenue Growth
- TAIT N/A
- CLDI N/A
- 52 Week Low
- TAIT $2.01
- CLDI $0.35
- 52 Week High
- TAIT $3.21
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- TAIT 54.47
- CLDI 36.62
- Support Level
- TAIT $2.01
- CLDI $0.40
- Resistance Level
- TAIT $2.35
- CLDI $0.46
- Average True Range (ATR)
- TAIT 0.07
- CLDI 0.04
- MACD
- TAIT 0.02
- CLDI 0.00
- Stochastic Oscillator
- TAIT 77.47
- CLDI 9.73
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.